Inactivating mutations in the ALK1 gene cause hereditary haemorrhagic telangiectasia type 2 (HHT2), a disabling disease characterized by excessive angiogenesis with arteriovenous malformations (AVMs). Here, ACVRL1 is linked to telangiectasia, hereditary hemorrhagic, type 2.